Disparity in the era of personalized medicine for epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359221148024
Abstract: The treatment of high-grade serous ovarian cancer and high-grade endometrioid ovarian cancer has seen significant improvements in recent years, with BRCA1/2 and homologous recombination status guiding a personalized approach which has resulted in improved patient… read more here.
Keywords: epithelial ovarian; ovarian cancer; disparity era; medicine ... See more keywords